Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation

Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation

Key points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors. 125I brachytherapy is a safe method with a curative effect.

Bibliographic Details
Main Authors: Wenliang Zhu, Zhihui Zhong, Huzheng Yan, Huanqing Guo, Meigui Xiao, Xu He, Fei Gao, Fujun Zhang
Format: Article
Language:English
Published: SpringerOpen 2022-12-01
Series:Insights into Imaging
Subjects:
125I brachytherapy
Hepatocellular carcinoma
Local residual or recurrent
Thermal ablation
Online Access:https://doi.org/10.1186/s13244-022-01327-z

Internet

https://doi.org/10.1186/s13244-022-01327-z

Similar Items